BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 10, 2003
View Archived Issues
A Chain Of Fanconi Anemia Genes Links To Ovarian Cancer Cells Via Odd BRCA Breast Cancer Genes
Read More
Canadian Companies Inflazyme, GlycoDesign Plan C$12.8M Merger
Read More
Antigenics' Leukemia Vaccine AG-858 Enters Phase II Study
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
SangStat's Ulcerative Colitis Drug Positive In Phase II, Fails Crohn's
With a new CEO installed and a recent favorable court ruling, SangStat Medical Corp. chalked up more good news Wednesday: positive preliminary Phase II data with RDP58, its drug for ulcerative colitis. (BioWorld Today)
Read More
Administration Seeks Support For Countermeasures Program
Read More